                               SEQUENCE LISTING

<110> REGENTS OF THE UNIVERSITY OF MINNESOTA
 
<120> CD200 INHIBITORS AND METHODS OF USE THEREOF

<130> 09531.368WO1

<140> PCT/US2016/060164
<141> 2016-11-02

<150> 62/250,376
<151> 2015-11-03

<160> 20    

<170> PatentIn version 3.5

<210> 1
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Asn Thr Ile Gly Asp Gly Gly Cys Tyr 
1               5                   


<210> 2
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Arg Cys Ser Leu Lys Thr Ser Gln Glu 
1               5                   


<210> 3
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Thr Ala Ser Leu Arg Cys Ser Leu Lys Thr Ser Gln Glu 
1               5                   10              


<210> 4
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Leu Phe Asn Thr Phe Gly Ser Gln Lys Val Ser Gly Thr 
1               5                   10              


<210> 5
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Ser Gln Lys Val Ser Gly Thr Ala Cys Leu Thr Leu Tyr 
1               5                   10              


<210> 6
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Ser Pro Glu Asn Met Val Thr Tyr Ser Lys Thr 
1               5                   10      


<210> 7
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Thr Tyr Ser Lys Thr His Gly Val Val Thr Gln 
1               5                   10      


<210> 8
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 8
Val Thr Trp Gln Lys Lys Lys Ala Val Ser Pro Glu Asn 
1               5                   10              


<210> 9
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 9
Val Thr Trp Gln Lys Lys Lys Ala Val Ser Pro Ala Asn 
1               5                   10              


<210> 10
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 10
Asn Ile Thr Leu Glu Asp Glu Gly Cys Tyr Met Cys Leu Phe Asn 
1               5                   10                  15  


<210> 11
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 11
Val Thr Phe Ser Glu Asn His Gly Val Val Ile Gln Pro Ala Tyr 
1               5                   10                  15  


<210> 12
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 12
Cys Leu Phe Asn Thr Phe Gly Phe Gly Lys Ile Ser Gly Thr Ala 
1               5                   10                  15  


<210> 13
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 13
Ser Gln Lys Val Ser Ala Thr Ala Cys Leu Thr Leu Tyr 
1               5                   10              


<210> 14
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 14
Val Thr Trp Gln Lys Val Lys Pro Val Ser Leu Glu 
1               5                   10          


<210> 15
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 15
Asn Thr Thr Leu Glu Asp Glu Gly Cys Tyr Lys Cys 
1               5                   10          


<210> 16
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 16
Leu Phe Asn Thr Phe Gly Ser Gly Lys Ile Ser Gly 
1               5                   10          


<210> 17
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 17
Pro Ala Ser Leu Arg Cys Ser Leu Gln Asn Pro Glu 
1               5                   10          


<210> 18
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 18
Ser Ile Ile Asn Phe Glu Lys Leu 
1               5               


<210> 19
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 19
Glu Val Ser Gln Leu Glu Gln Leu Glu Ser Ile Ile Asn Phe Glu Lys 
1               5                   10                  15      


Leu Thr Glu Glu Trp Thr Ser Ser Asn Val Met 
            20                  25          


<210> 20
<211> 9
<212> PRT
<213> Cytomegalovirus 

<400> 20
Asn Leu Val Pro Met Val Ala Thr Val 
1               5                   


